![Nicole Wistuba](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nicole Wistuba
Amministratore Delegato presso The BioScience Ventures Group AG
Profilo
Dr. Nicole Wistuba is a Managing Director at The BioScience Ventures Group AG.
She is on the Board of Directors at ugichem GmbH, MagnaMedics GmbH, MaRVis Technologies GmbH, and APEPTICO Forschung & Entwicklung GmbH.
Dr. Wistuba also served on the board at Adriacell SpA.
She received her doctorate degree from the Wuerzburg Schweinfurt University of Applied Sciences.
Posizioni attive di Nicole Wistuba
Società | Posizione | Inizio |
---|---|---|
The BioScience Ventures Group AG
![]() The BioScience Ventures Group AG Investment ManagersFinance The BioSciences Ventures Group AG operates as an association of business angels. Through its network, the association is able to invests in start-up life sciences companies within Germany, Austria and Switzerland. The association is headquartered in Munich, Germany. | Amministratore Delegato | 19/08/2009 |
MaRVis Technologies GmbH | Direttore/Membro del Consiglio | 04/07/2011 |
Precedenti posizioni note di Nicole Wistuba
Società | Posizione | Fine |
---|---|---|
Adriacell SpA
![]() Adriacell SpA Miscellaneous Commercial ServicesCommercial Services Adriacell is a biotechnology company focused on the research and development of new generation biopharmaceuticals for the diagnosis and treatment of cancer. Its International team of highly qualified scientists is currently developing two: CROMOC, a tumor therapeutic agent and CERVIMAX which addresses the critical need for the early and accurate diagnosis of cervical cancer. Adriacell is a located in the Area Science Park of Trieste, Italy. | Direttore/Membro del Consiglio | 09/07/2012 |
APEPTICO Forschung & Entwicklung GmbH
![]() APEPTICO Forschung & Entwicklung GmbH Miscellaneous Commercial ServicesCommercial Services APEPTICO Forschung & Entwicklung GmbH develops and commercializes peptide-based therapeutics. Its products targeting chronic and life-threatening diseases. The firms peptide molecules correspond to validated, pharmacodynamic active structures and domains of well-known proteins and biopharmaceuticals. The company was founded by Franz Knauseder, Bernhard Fischer, Rudolf Lucas and Hermann Mascher in 2008 and is headquartered in Vienna, Austria. | Direttore/Membro del Consiglio | - |
MagnaMedics GmbH
![]() MagnaMedics GmbH Medical SpecialtiesHealth Technology MagnaMedics GmbH develops and markets biological diagnostic products. It specializes in the discovery and production of magnetic nano- and microparticles that are used in diagnostic kits for identifying biomarkers in body fluids. Its application areas encompass in-vitro diagnostics, genomics, protein and peptide, and research and development projects. It engages in partnerships with research and development laboratories and in-vitro diagnostics manufacturers. The company was founded by P. Mario Wuttke in 2003 and is headquartered in Aachen, Germany. | Direttore/Membro del Consiglio | - |
ugichem GmbH
![]() ugichem GmbH BiotechnologyHealth Technology ugichem GmbH develops and manufactures antisense drugs. Its Ugimer platform intends to develop a pipeline of antisense drugs addressing unmet medical needs in indications involving inflammatory processes with focus on rheumatoid arthritis. The company was founded in 2003 by Ivar Ugi, Holger Bock, Thomas Lindhorst and is headquartered in Innsbruck, Austria. | Direttore/Membro del Consiglio | - |
Formazione di Nicole Wistuba
Wuerzburg Schweinfurt University of Applied Sciences | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 6 |
---|---|
Adriacell SpA
![]() Adriacell SpA Miscellaneous Commercial ServicesCommercial Services Adriacell is a biotechnology company focused on the research and development of new generation biopharmaceuticals for the diagnosis and treatment of cancer. Its International team of highly qualified scientists is currently developing two: CROMOC, a tumor therapeutic agent and CERVIMAX which addresses the critical need for the early and accurate diagnosis of cervical cancer. Adriacell is a located in the Area Science Park of Trieste, Italy. | Commercial Services |
The BioScience Ventures Group AG
![]() The BioScience Ventures Group AG Investment ManagersFinance The BioSciences Ventures Group AG operates as an association of business angels. Through its network, the association is able to invests in start-up life sciences companies within Germany, Austria and Switzerland. The association is headquartered in Munich, Germany. | Finance |
ugichem GmbH
![]() ugichem GmbH BiotechnologyHealth Technology ugichem GmbH develops and manufactures antisense drugs. Its Ugimer platform intends to develop a pipeline of antisense drugs addressing unmet medical needs in indications involving inflammatory processes with focus on rheumatoid arthritis. The company was founded in 2003 by Ivar Ugi, Holger Bock, Thomas Lindhorst and is headquartered in Innsbruck, Austria. | Health Technology |
MagnaMedics GmbH
![]() MagnaMedics GmbH Medical SpecialtiesHealth Technology MagnaMedics GmbH develops and markets biological diagnostic products. It specializes in the discovery and production of magnetic nano- and microparticles that are used in diagnostic kits for identifying biomarkers in body fluids. Its application areas encompass in-vitro diagnostics, genomics, protein and peptide, and research and development projects. It engages in partnerships with research and development laboratories and in-vitro diagnostics manufacturers. The company was founded by P. Mario Wuttke in 2003 and is headquartered in Aachen, Germany. | Health Technology |
MaRVis Technologies GmbH | |
APEPTICO Forschung & Entwicklung GmbH
![]() APEPTICO Forschung & Entwicklung GmbH Miscellaneous Commercial ServicesCommercial Services APEPTICO Forschung & Entwicklung GmbH develops and commercializes peptide-based therapeutics. Its products targeting chronic and life-threatening diseases. The firms peptide molecules correspond to validated, pharmacodynamic active structures and domains of well-known proteins and biopharmaceuticals. The company was founded by Franz Knauseder, Bernhard Fischer, Rudolf Lucas and Hermann Mascher in 2008 and is headquartered in Vienna, Austria. | Commercial Services |
- Borsa valori
- Insiders
- Nicole Wistuba